Surprisingly, this study showed that macrophages displaying trastuzumab-mediated ADCP downregulated NK cell-mediated ADCC and anti-tumor immune response by CD8+ T cells due to PD-L1 and IDO upregulation by inflammasome activation 22. The gene discussed is CD274; the disease is neoplasm.